1
|
McInally W, Taylor V, de Los Rios de la Serna CD, Sulosaari V, Trigoso E, Gomes SMR, Dias ARC, Piskorjanac S, Tanay MA, Hálfdánardóttir H, Dowling M. An Innovation in Cancer Nursing Education Across Europe: A Pilot Evaluation. J Cancer Educ 2024:10.1007/s13187-024-02424-x. [PMID: 38592656 DOI: 10.1007/s13187-024-02424-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 03/17/2024] [Indexed: 04/10/2024]
Abstract
The European Oncology Nursing Society (EONS) is a pan-European not for profit society involving approximately 28,000 cancer nurses from 32 countries in the region. The European College of Cancer Nursing (ECCN) exists under the umbrella of EONS and was established in 2020 with a strategic priority to develop, promote and deliver educational opportunities for nurses across Europe. ECCN introduced a pilot on-line education programme for 20 nurses in January 2023. This study evaluated participating nurses' views and experience of learning on the pilot programme. The study adopted a mixed method approach guided by the four levels of the Kirkpatrick theoretical framework. A dominant focus on qualitative data was used with supplementary quantitative data. The Standards for Reporting Qualitative Research (SRQR) was followed. Eleven nurses completed the pre-pilot online questionnaire (response rate 65%) and seven (n = 7) completed the post-pilot questionnaire (41% response rate). Five (n = 5) nurses participated in two focus group interviews. Data analysis resulted in the development of four overarching themes: A wider world of cancer nursing; Shapeless mentorship; Impact on Practice; Learning online and what now? On commencement of online education programmes, nurses value a structured timetable and support from nursing management to maximise engagement with the learning materials.
Collapse
Affiliation(s)
- Wendy McInally
- School of Health, Wellbeing and Social Care, The Open University, Milton Keynes, UK.
| | - Vanessa Taylor
- School of Health and Human Sciences, University of Huddersfield, England, UK
| | | | - Virpi Sulosaari
- Health and Well-Being, Turku University of Applied Sciences, Turku, Finland
| | | | | | - Ana Rita Cesario Dias
- Faculty of Dental Medicine, Health Centro Hospitalar E Universitário de Lisboa Central, Lisbon, Portugal
| | | | - Mary Anne Tanay
- Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, King's College London, London, UK
| | | | - Maura Dowling
- School of Nursing and Midwifery, University of Galway, Galway, Ireland
| |
Collapse
|
2
|
Tanay MA, Quiambao-Udan J, Soriano O, Aquino G, Valera PM. Filipino nurses' experiences and perceptions of the impact of climate change on healthcare delivery and cancer care in the Philippines: a qualitative exploratory survey. Ecancermedicalscience 2023; 17:1622. [PMID: 38414932 PMCID: PMC10898899 DOI: 10.3332/ecancer.2023.1622] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2023] [Indexed: 02/29/2024] Open
Abstract
Background Because of its geographical location, the Philippines is vulnerable to the effects of climate change and almost all types of natural hazards such as typhoons, earthquakes, and volcanic eruptions. Cancer is one of the leading causes of death in the Philippines and is one of the major public health concerns. Little is known about how climate change affects cancer services in the Philippines. As the biggest workforce in most institutions, having awareness and knowledge about disaster preparedness and management among nurses can help in reducing the devastating effects of natural disasters on health services. Thus, it is important to understand Filipino nurses' experiences and perception of the impact of climate change on healthcare delivery and cancer care in the Philippines. Aim This study explored Filipino nurses' experiences and perception of the impact of climate change on healthcare delivery and cancer care in the Philippines. Methods This is a descriptive qualitative exploratory study. Participants were recruited using the snowballing technique and completed an online survey. Forty-six nurses who were working in Luzon, Philippines at the time of the data collection were included in the analysis. Data were analysed using thematic analysis. Findings Three themes were identified, namely: (1) effects of climate change causing disruption and delay in provision of patient care, (2) impact of climate change on nurses and a deep sense of duty, and (3) perceived impact on patients with cancer. Conclusion Our study findings contribute to the existing literature that focuses on the impact of climate change-related events such as typhoons and floods on healthcare services and nursing staff. Several areas of cancer care are also impacted, particularly delays in treatment such as chemotherapy. Despite the challenges, the nurses in our study demonstrated a deep sense of commitment in carrying out their roles.
Collapse
Affiliation(s)
- Mary Anne Tanay
- Faculty of Nursing, Midwifery and Palliative Care, King's College London, SE1 8WA London, UK
- https://orcid.org/0000-0002-3637-6742
| | | | - Oliver Soriano
- Lancashire and South Cumbria NHS Foundation Trust, PR5 6AW Lancashire, UK
| | | | | |
Collapse
|
3
|
Tanay MA, Diez de Los Rios de la Serna C, Boland V, Lopes AMDS, Wingfield K, Chircop D, Dornan M, Suchodolska G, Yıldız Aytaç G, Kurt B, Colomer-Lahiguera S. Patient and public involvement in research: Reflections and experiences of doctoral cancer nurse researchers in Europe. Eur J Oncol Nurs 2023; 64:102351. [PMID: 37290166 DOI: 10.1016/j.ejon.2023.102351] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2022] [Revised: 01/23/2023] [Accepted: 05/21/2023] [Indexed: 06/10/2023]
Abstract
PURPOSE Early career researchers lack guidance about patient and public involvement (PPI). The overall aim of the study was to explore the knowledge and experiences of using PPI in research among doctoral students who are registered nurses. METHODS This qualitative study included findings generated from reflective essays and focus groups involving ten registered cancer nurses who are undertaking doctoral research. The study has two stages of data collection. Participants initially wrote a reflective essay using a set of guiding questions to structure a response which was subsequently analysed. Two focus groups were then conducted to provide further insight into the themes identified in the reflective essays. Reflective thematic analysis was used to identify, name, and define the final themes. RESULTS There were ten participants from seven countries and were at various stages of their doctoral study. Analysis of data from reflective essays (n = 10) and focus groups (n = 2) identified four themes namely, (a) evolving recognition and appreciation of PPI, (b) embracing PPI and impact on doctoral studies, (c) the influence of the research environment, and (d) the need to empower doctoral students to integrate PPI in their research journey. CONCLUSION Participants reported differing experiences of PPI awareness showing disparity in guidance about PPI for junior researchers across Europe. We recommend provision of early PPI training for doctoral students to support and encourage involvement of patients and the public in their research. Opportunities for sharing PPI experiences to help improve PPI culture in research environments that support doctoral students should be explored.
Collapse
Affiliation(s)
- Mary Anne Tanay
- Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, King's College London, United Kingdom.
| | | | - Vanessa Boland
- School of Nursing and Midwifery, Trinity College Dublin, Ireland
| | - André Manuel Da Silva Lopes
- Institute of Higher Education and Research in Healthcare-IUFRS, University of Lausanne, Lausanne University Hospital, Switzerland
| | - Karen Wingfield
- School of Healthcare Sciences, Cardiff University, United Kingdom
| | - Daren Chircop
- School of Health Sciences, University of Southampton, United Kingdom
| | - Mark Dornan
- Institute of Nursing and Health Research, Ulster University, United Kingdom
| | - Grażyna Suchodolska
- Department of Oncology & Radiotherapy, Faculty of Medicine, Medical University of Gdańsk, Poland
| | - Gülşah Yıldız Aytaç
- Faculty of Nursing, Psychiatric Nursing Department, Hacettepe University, Turkey
| | - Berna Kurt
- Faculty of Nursing, Internal Medicine Nursing Department, Hacettepe University, Turkey
| | - Sara Colomer-Lahiguera
- Institute of Higher Education and Research in Healthcare-IUFRS, University of Lausanne, Lausanne University Hospital, Switzerland
| |
Collapse
|
4
|
McInally W, Taylor V, Diez de Los Rios C, Sulosaari V, Dowling M, Trigoso E, Rodrigues Gomes SM, Cesario Dias Ycn AR, Piskorjanac S, Tanay MA, Hálfdánardóttir H. Innovations in cancer nursing education across Europe. Eur J Oncol Nurs 2023; 63:102305. [PMID: 37003896 DOI: 10.1016/j.ejon.2023.102305] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2023] [Accepted: 02/21/2023] [Indexed: 03/02/2023]
Affiliation(s)
| | | | | | | | | | - Eugenia Trigoso
- Education Working Group, Valencia Hospital, Spain; University and Polytechnic Hospital LA FE, Valencia, Spain
| | | | | | | | | | | |
Collapse
|
5
|
Tanay MA, Armes J. Lived experiences and support needs of women who developed chemotherapy-induced peripheral neuropathy following treatment for breast and ovarian cancer. Eur J Cancer Care (Engl) 2019; 28:e13011. [PMID: 30790382 DOI: 10.1111/ecc.13011] [Citation(s) in RCA: 21] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2017] [Revised: 11/07/2018] [Accepted: 01/17/2019] [Indexed: 02/01/2023]
Abstract
OBJECTIVES This study explored lived experiences of women who developed chemotherapy-induced peripheral neuropathy (CIPN) following treatment for breast and ovarian cancer. It also explored cancer survivors' perceptions of information and advice offered by clinicians about CIPN and for managing CIPN. METHODS The study was advertised through cancer charity websites and social media accounts. Purposeful, convenience sampling was carried out using set eligibility criteria. Individuals with diagnosis of breast or ovarian cancer who experienced or are still experiencing CIPN were recruited. Fifteen semi-structured interviews were conducted. Data were analysed using interpretative phenomenological analysis (IPA). RESULTS Similar to previous studies, participants used comparisons to describe their symptoms. Four main themes emerged from the analysis: (a) struggle to process CIPN information, (b) information and trust are key in the treatment decision-making process, (c) experience of symptom reporting and (d) challenges of managing symptoms. Findings suggest interventions to improve understanding of CIPN risk are needed in practice. CONCLUSION A better and broader understanding of the patient experience of CIPN could pave the way for improved communication, assessment and management of symptoms. Results suggest the need for interventions to guide cancer survivors to recognise and report CIPN symptoms early and address the impact of CIPN symptoms in their lives.
Collapse
Affiliation(s)
- Mary Anne Tanay
- Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, King's College London, London, UK
| | - Jo Armes
- School of Health Sciences, University of Surrey, Guildford, UK
| |
Collapse
|
6
|
Abstract
AIM To identify the perceptions of nurses (working with adult patients) about potential barriers to the use of humour in practice. DESIGN/METHODS A literature review of qualitative research and thematic synthesis were undertaken. Four key databases were systematically searched and manual search conducted. RESULTS The review and thematic analysis identified five key themes from the included studies: (1) inappropriate situations, (2) being a new or junior nurse, (3) the impact on nurse professionalism, (4) differences in personality, and (5) environmental factors. CONCLUSION Results from this thematic synthesis identified perceptions of nurses about potential barriers that prevent the use of humour in practice. The extent to which nurses use humour is related to personality factors, but is also affected by external and social factors. Reluctance in its use in practice is influenced by views that humour is unprofessional; with senior nurses found to have a pertinent role in influencing its use.
Collapse
Affiliation(s)
| | - Mary Anne Tanay
- b Florence Nightingale Faculty of Nursing and Midwifery , King's College London , London , UK
| |
Collapse
|
7
|
Miah AB, Bhide SA, Del Rosario L, Matthews J, Nicol R, Tanay MA, Gupta S, Zaidi SH, Newbold KL, Harrington KJ, Nutting CM. Induction Chemotherapy Followed by Chemo-intensity-modulated Radiotherapy for Locally Advanced Nasopharyngeal Cancer. Clin Oncol (R Coll Radiol) 2016; 28:e61-7. [PMID: 26876458 DOI: 10.1016/j.clon.2016.01.012] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2015] [Revised: 12/01/2015] [Accepted: 12/30/2015] [Indexed: 11/16/2022]
Abstract
AIMS To determine the toxicity and tumour control rates after chemo-intensity-modulated radiotherapy (chemo-IMRT) for locally advanced nasopharyngeal cancers (LA-NPC). MATERIALS AND METHODS Patients with LA-NPC were enrolled in a trial to receive induction chemotherapy followed by parotid-sparing chemo-IMRT. The primary site and involved nodal levels received 65 Gy in 30 fractions and at risk nodal levels received 54 Gy in 30 fractions. Incidence of ≥grade 2 subjective xerostomia was the primary end point. Secondary end points included incidences of acute and late toxicities and survival outcomes. RESULTS Forty-two patients with American Joint Committee on Cancer stages II (12%), III (26%) and IV (62%) (World Health Organization subtype: I [5%]; II [40%]; III [55%]) completed treatment between January 2006 and April 2010 with a median follow-up of 32 months. Incidences of ≥grade 2 acute toxicities were: dysphagia 83%; xerostomia 76%; mucositis 97%; pain 76%; fatigue 99% and ototoxicity 12%. At 12 months, ≥grade 2 subjective xerostomia was observed in 31%, ototoxicitiy in 13% and dysphagia in 4%. Two year locoregional control was 86.2% (95% confidence interval: 70.0-94.0) with 2 year progression-free survival at 78.4% (61.4-88.6) and 2 year overall survival at 85.9% (69.3-93.9). CONCLUSIONS Chemo-IMRT for LA-NPC is feasible with good survival outcomes. At 1 year, 31% experience ≥grade 2 subjective xerostomia.
Collapse
Affiliation(s)
- A B Miah
- Head and Neck Unit, The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK
| | - S A Bhide
- Head and Neck Unit, The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK
| | - L Del Rosario
- Head and Neck Unit, The Royal Marsden NHS Foundation Trust, London, UK
| | - J Matthews
- Head and Neck Unit, The Royal Marsden NHS Foundation Trust, London, UK
| | - R Nicol
- Head and Neck Unit, The Royal Marsden NHS Foundation Trust, London, UK
| | - M A Tanay
- Head and Neck Unit, The Royal Marsden NHS Foundation Trust, London, UK
| | - S Gupta
- Head and Neck Unit, The Royal Marsden NHS Foundation Trust, London, UK
| | - S H Zaidi
- Head and Neck Unit, The Royal Marsden NHS Foundation Trust, London, UK
| | - K L Newbold
- Head and Neck Unit, The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK
| | - K J Harrington
- Head and Neck Unit, The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK
| | - C M Nutting
- The Institute of Cancer Research, London, UK.
| |
Collapse
|
8
|
Harrington KJ, Hingorani M, Tanay MA, Hickey J, Bhide SA, Clarke PM, Renouf LC, Thway K, Sibtain A, McNeish IA, Newbold KL, Goldsweig H, Coffin R, Nutting CM. Phase I/II study of oncolytic HSV GM-CSF in combination with radiotherapy and cisplatin in untreated stage III/IV squamous cell cancer of the head and neck. Clin Cancer Res 2010; 16:4005-15. [PMID: 20670951 DOI: 10.1158/1078-0432.ccr-10-0196] [Citation(s) in RCA: 191] [Impact Index Per Article: 13.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
PURPOSE This study sought to define the recommended dose of JS1/34.5-/47-/GM-CSF, an oncolytic herpes simplex type-1 virus (HSV-1) encoding human granulocyte-macrophage colony-stimulating factor (GM-CSF), for future studies in combination with chemoradiotherapy in patients with squamous cell cancer of the head and neck (SCCHN). EXPERIMENTAL DESIGN Patients with stage III/IVA/IVB SCCHN received chemoradiotherapy (70 Gy/35 fractions with concomitant cisplatin 100 mg/m(2) on days 1, 22, and 43) and dose-escalating (10(6), 10(6), 10(6), 10(6) pfu/mL for cohort 1; 10(6), 10(7), 10(7), 10(7) for cohort 2; 10(6), 10(8), 10(8), 10(8) for cohort 3) JS1/34.5-/47-/GM-CSF by intratumoral injection on days 1, 22, 43, and 64. Patients underwent neck dissection 6 to 10 weeks later. Primary end points were safety and recommended dose/schedule for future study. Secondary end points included antitumor activity (radiologic, pathologic). Relapse rates and survival were also monitored. RESULTS Seventeen patients were treated without delays to chemoradiotherapy or dose-limiting toxicity. Fourteen patients (82.3%) showed tumor response by Response Evaluation Criteria in Solid Tumors, and pathologic complete remission was confirmed in 93% of patients at neck dissection. HSV was detected in injected and adjacent uninjected tumors at levels higher than the input dose, indicating viral replication. All patients were seropositive at the end of treatment. No patient developed locoregional recurrence, and disease-specific survival was 82.4% at a median follow-up of 29 months (range, 19-40 months). CONCLUSIONS JS1/34.5-/47-/GM-CSF combined with cisplatin-based chemoradiotherapy is well tolerated in patients with SCCHN. The recommended phase II dose is 10(6), 10(8), 10(8), 10(8). Locoregional control was achieved in all patients, with a 76.5% relapse-free rate so far. Further study of this approach is warranted in locally advanced SCCHN.
Collapse
|